These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 5399721)
1. [I-192 in epistaxis caused by Rendu-Osler disease]. Gaia F Boll Mal Orecch Gola Naso; 1969; 87(5):410-23. PubMed ID: 5399721 [No Abstract] [Full Text] [Related]
2. [Endonasal contact radiotherapy of Rendu-Osler diseases with iridium-192]. Pierquin B; Koskas Y; Chassagne D Ann Otolaryngol Chir Cervicofac; 1969 Mar; 86(3):127-31. PubMed ID: 5769826 [No Abstract] [Full Text] [Related]
3. [Surgical treatment of the endonasal manifestations of Rendu-Osler disease]. Gignoux M; Martin H; Cajgfinger H; Gignoux B; Gadot P J Med Lyon; 1970 Nov; 51(197):1967-8 passim. PubMed ID: 4949976 [No Abstract] [Full Text] [Related]
5. External beam radiotherapy for severe epistaxis from Osler-Weber-Rendu disease. Harwood AR; Wojak JC; Barry R J La State Med Soc; 2002; 154(3):154-5. PubMed ID: 12139363 [TBL] [Abstract][Full Text] [Related]
7. Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis. Folz BJ; Wollstein AC; Lippert BM; Werner JA Am J Rhinol; 2005; 19(1):65-70. PubMed ID: 15794077 [TBL] [Abstract][Full Text] [Related]
8. Otorhinolaryngological manifestations of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu Disease). Yanagisawa K; Yanagisawa E Ear Nose Throat J; 1996 Jun; 75(6):336-7. PubMed ID: 8689960 [No Abstract] [Full Text] [Related]
9. [Rendu-Osler disease. Follow-up of 6 patients treated by embolization. Nasal telecobaltotherapy in a refractory case]. Esparcia Navarro M; Ferrer Baixauli F; Moya Albiol S; Vento Torres D; García Callejo FJ; Soler Marquessins F; Marco Algarra J Acta Otorrinolaringol Esp; 1999 Apr; 50(3):197-201. PubMed ID: 10362862 [TBL] [Abstract][Full Text] [Related]
10. Narrow-band imaging in the endoscopic evaluation of hereditary hemorrhagic telangiectasia patients. Pagella F; Pusateri A; Chu F; Caputo M; Danesino C; Matti E Laryngoscope; 2013 Dec; 123(12):2967-8. PubMed ID: 23929661 [No Abstract] [Full Text] [Related]
11. Management of epistaxis in Rendu-Osler disease: is brachytherapy effective? Pohar S; Mazeron JJ; Ghilezan M; Le Bourgeois JP; Pierquin B Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1073-7. PubMed ID: 8262830 [TBL] [Abstract][Full Text] [Related]
12. [Surgical treatment of epistaxis in Osler-Rendu-Weber disease]. Stastný B; Kroslák M Cesk Otolaryngol; 1981 Jan; 30(1):53-6. PubMed ID: 7214573 [No Abstract] [Full Text] [Related]
13. [Rendu-Osler disease: apropos of 50 cases followed at the Gustave-Roussy Institute]. Cachin Y; Sauvage JP; Schwaab G Ann Otolaryngol Chir Cervicofac; 1976; 93(1-2):103-8. PubMed ID: 970861 [TBL] [Abstract][Full Text] [Related]
18. [Epistaxis in Rendu-Weber-Osler disease. The role of brachytherapy]. Turcato G; Pizzi GB; Polico R; Antonello M; Busetto M Acta Otorhinolaryngol Ital; 1996 Dec; 16(6):513-6. PubMed ID: 9381921 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid]. Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407 [TBL] [Abstract][Full Text] [Related]
20. Natural history and control of epistaxis in a group of German patients with Rendu-Osler-Weber disease. Folz BJ; Tennie J; Lippert BM; Werner JA Rhinology; 2005 Mar; 43(1):40-6. PubMed ID: 15844501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]